These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8573915)

  • 21. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of pro-urokinase and urokinase on the fibrinolytic system in man.
    Trübestein G; Popov S; Wolf H; Welzel D
    Haemostasis; 1987; 17(4):238-44. PubMed ID: 2442078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Massive amounts of tissue factor induce fibrinogenolysis without tissue hypoperfusion in rats.
    Hayakawa M; Gando S; Ieko M; Honma Y; Homma T; Yanagida Y; Kubota N; Uegaki S; Sawamura A; Asakura H
    Shock; 2013 Jun; 39(6):514-9. PubMed ID: 23542400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage.
    Hayashi S; Yamada K
    Thromb Res; 1979; 16(3-4):393-400. PubMed ID: 92817
    [No Abstract]   [Full Text] [Related]  

  • 25. Severe bleeding tendency caused by a rare complication of excessive fibrinolysis with disseminated intravascular coagulation in a 51-year-old Japanese man with prostate cancer: a case report.
    Wada Y; Uchiba M; Kawano Y; Kai N; Takahashi W; Honda J; Tanoue K; Maeda Y; Murakami Y; Eto M; Imamura T
    J Med Case Rep; 2012 Nov; 6():378. PubMed ID: 23130841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
    Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
    Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of heparin on chronically induced intravascular coagulation in dogs.
    Owen CA; Bowie EJ
    Am J Physiol; 1975 Aug; 229(2):449-54. PubMed ID: 1163671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of antithrombin and argatroban on disseminated intravascular coagulation parameters in a patient with septic shock.
    Beyer J; Halbritter K; Weise M; Schellong S
    Thromb Res; 2009 Jul; 124(3):383-6. PubMed ID: 19062078
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H; Takahashi H; Chiba K; Tamura K
    Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of disseminated intravascular coagulation].
    Koyama T
    Rinsho Ketsueki; 2010 Jan; 51(1):52-6. PubMed ID: 20134140
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of localized and systemic amyloidosis based on coagulation and fibrinolysis parameters.
    Suga N; Miura N; Kitagawa W; Morita H; Banno S; Imai H
    Amyloid; 2012 Jun; 19(2):61-5. PubMed ID: 22417630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis.
    Izquierdo R; Sandberg L; Squillaci G; Hoppensteadt D; Walenga J; Fareed J; Prinz R
    Am Surg; 1984 Jun; 50(6):317-23. PubMed ID: 6203448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of rethrombosis after thrombolytic therapy: angioscopic findings and investigation of the coagulation system in dogs.
    Maki A; Shirato C; Ohguchi M; Aoki N; Ochiai N; Taguchi S; Aoki I; Ishikawa K
    Angiology; 1998 Jun; 49(6):447-53. PubMed ID: 9631890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epinephrine exerts anticoagulant effects during human endotoxemia.
    van der Poll T; Levi M; Dentener M; Jansen PM; Coyle SM; Braxton CC; Buurman WA; Hack CE; ten Cate JW; Lowry SF
    J Exp Med; 1997 Mar; 185(6):1143-8. PubMed ID: 9091588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis.
    Booth NA; Bennett B
    Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombin inhibitory and clot-specific fibrinolytic activities of the urokinase variant, M23 (rscu-PA-40 kDa/Hir).
    Schneider J; Wnendt S; Saunders D; Heinzel-Wieland R; Wilffert B; Steffens G
    Eur J Pharmacol; 1996 Apr; 302(1-3):69-77. PubMed ID: 8790994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anticoagulant].
    Mitome J; Yamamoto H
    Nihon Rinsho; 2004 May; 62 Suppl 5():368-73. PubMed ID: 15197947
    [No Abstract]   [Full Text] [Related]  

  • 40. [Biological profile of the 1st 4 hours of a thrombolytic treatment combining urokinase with lysyl-plasminogen].
    Roncato M; Vitoux JF; Pernes JM; Aiach M; Fiessinger JN; Gaux JC; Housset E; Leclerc M
    Ann Biol Clin (Paris); 1985; 43(6):851-5. PubMed ID: 3832977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.